Leerink Partners on Kalvista Pharmaceuticals Inc (KALV): 'we continue to view this as a launch investors should own'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to Leerink Partners on Kalvista Pharmaceuticals Inc (KALV): 'we continue to view this as a launch investors should own'
(NASDAQ: KALV) Delayed: 27.00 --0 (-0%)
Previous Close $27.00    52 Week High $ 
Open $27.00    52 Week Low $ 
Day High $27.00    P/E N/A 
Day Low $27.00    EPS $ 
Volume 9,753